Nagi S El Saghir (Nagi El-Saghir)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO global oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yen-Shen Lu, Eznal Izwadi Bin Mohd Mahidin, Hamdy Azim, Yeşim Eralp, Yoon Sim Yap, Seock-Ah Im, Julie Rihani, Erhan Gokmen, Ahmed El Bastawisy, Nuri Karadurmus, Yueh Ni Lim, Chun Sen Lim, Le Thanh Duc, Wei-Pang Chung, Govind Babu K, Konstantin Penkov, James Bowles, Teresa Delgar Alfaro, Jiwen Wu, Melissa Gao, Khemaies Slimane, Nagi S El Saghir
Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Sana A Al Sukhun, Sarah Temin, Carlos Henrique Barrios, Nicoleta Zenovia Antone, Yanin Chavarri Guerra, Mariana Chavez Mac Gregor, Rakesh Chopra, Michael A Danso, Henry Leonidas Gomez, N'Da Marcelin Homian, Alaa Kandil, Benda Kithaka, Bogda Koczwara, Beverly Moy, Gertrude Nakigudde, Fernando Enrique Petracci, Hope S Rugo, Nagi S El Saghir, Banu K Arun
Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified Guideline. JCO global oncology 10 (2024)
Hesham Elghazaly, Hamdy A Azim, Hope S Rugo, David Cameron, Sandra M Swain, Curigliano Giuseppe, Nadia Harbeck, Debu Tripathy, Banu K Arun, Matti Aapro, Martine Piccart, Fatima Cardoso, Joseph Gligorov, Hagar I Elghazawy, Nagi S El Saghir, Frederique Penault-Llorca, Edith A Perez, Philip Poortmans, Hany Abdelaziz, Heba M El-Zawahry, Loay Kassem, Mohamed Sabry, Giuseppe Viale, Sana Al-Sukhun, Neven Gado, Jessica W T Leung, Lobna Ezz Elarab, Maria João Cardoso, Khaled Abdel Karim, Meteb Foheidi, Merit M Elmaadawy, PierFranco Conte, Ashraf S M Selim, Alaa Kandil, Rasha M Kamal, Ruslan M Paltuev, Valentina Guarneri, Omalkhair Abulkhair, Omar Zakaria, Mehra Golshan, Roberto Orecchia, Manal ElMahdy, Ahmed M Abdel-Aziz, Nermean Bahie Eldin
Tailoring neoadjuvant systemic therapy in breast cancer: "The advent of a personalized approach"-The Breast-Gynecological and Immuno-Oncology International Cancer Conference (BGICC) consensus and recommendations. Cancer 130 (19) (2024)
Yen-Shen Lu, Eznal Izwadi Bin Mohd Mahidin, Hamdy Azim, Yeşim Eralp, Yoon Sim Yap, Seock-Ah Im, Julie Rihani, Erhan Gokmen, Ahmed El Bastawisy, Nuri Karadurmus, Yueh Ni Lim, Chun Sen Lim, Le Thanh Duc, Wei-Pang Chung, Govind Babu K, Konstantin Penkov, James Bowles, Teresa Delgar Alfaro, Jiwen Wu, Melissa Gao, Khemaies Slimane, Nagi S El Saghir
Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Yen-Shen Lu, Eznal Izwadi Bin Mohd Mahidin, Hamdy Azim, Yeşim Eralp, Yoon Sim Yap, Seock-Ah Im, Julie Rihani, Erhan Gokmen, Ahmed El Bastawisy, Nuri Karadurmus, Yueh Ni Lim, Chun Sen Lim, Le Thanh Duc, Wei-Pang Chung, Govind Babu K, Konstantin Penkov, James Bowles, Teresa Delgar Alfaro, Jiwen Wu, Melissa Gao, Khemaies Slimane, Nagi S El Saghir
Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Yen-Shen Lu, Eznal Izwadi Bin Mohd Mahidin, Hamdy Azim, Yeşim Eralp, Yoon Sim Yap, Seock-Ah Im, Julie Rihani, Erhan Gokmen, Ahmed El Bastawisy, Nuri Karadurmus, Yueh Ni Lim, Chun Sen Lim, Le Thanh Duc, Wei-Pang Chung, Govind Babu K, Konstantin Penkov, James Bowles, Teresa Delgar Alfaro, Jiwen Wu, Melissa Gao, Khemaies Slimane, Nagi S El Saghir
Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Sana A Al Sukhun, Sarah Temin, Carlos Henrique Barrios, Nicoleta Zenovia Antone, Yanin Chavarri Guerra, Mariana Chavez Mac Gregor, Rakesh Chopra, Michael A Danso, Henry Leonidas Gomez, N'Da Marcelin Homian, Alaa Kandil, Benda Kithaka, Bogda Koczwara, Beverly Moy, Gertrude Nakigudde, Fernando Enrique Petracci, Hope S Rugo, Nagi S El Saghir, Banu K Arun
Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified Guideline. JCO global oncology 10 (2024)
Hesham Elghazaly, Hamdy A Azim, Hope S Rugo, David Cameron, Sandra M Swain, Curigliano Giuseppe, Nadia Harbeck, Debu Tripathy, Banu K Arun, Matti Aapro, Martine Piccart, Fatima Cardoso, Joseph Gligorov, Hagar I Elghazawy, Nagi S El Saghir, Frederique Penault-Llorca, Edith A Perez, Philip Poortmans, Hany Abdelaziz, Heba M El-Zawahry, Loay Kassem, Mohamed Sabry, Giuseppe Viale, Sana Al-Sukhun, Neven Gado, Jessica W T Leung, Lobna Ezz Elarab, Maria João Cardoso, Khaled Abdel Karim, Meteb Foheidi, Merit M Elmaadawy, PierFranco Conte, Ashraf S M Selim, Alaa Kandil, Rasha M Kamal, Ruslan M Paltuev, Valentina Guarneri, Omalkhair Abulkhair, Omar Zakaria, Mehra Golshan, Roberto Orecchia, Manal ElMahdy, Ahmed M Abdel-Aziz, Nermean Bahie Eldin
Tailoring neo/adjuvant systemic therapy in breast cancer: "The advent of a personalized approach"-The Breast-Gynecological and Immuno-Oncology International Cancer Conference (BGICC) consensus and recommendations. Cancer (2024)
Yen-Shen Lu, Eznal Izwadi Bin Mohd Mahidin, Hamdy Azim, Yeşim Eralp, Yoon Sim Yap, Seock-Ah Im, Julie Rihani, Erhan Gokmen, Ahmed El Bastawisy, Nuri Karadurmus, Yueh Ni Lim, Chun Sen Lim, Le Thanh Duc, Wei-Pang Chung, Govind Babu K, Konstantin Penkov, James Bowles, Teresa Delgar Alfaro, Jiwen Wu, Melissa Gao, Khemaies Slimane, Nagi S El Saghir
Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Sana A Al Sukhun, Sarah Temin, Carlos Henrique Barrios, Nicoleta Zenovia Antone, Yanin Chavarri Guerra, Mariana Chavez Mac Gregor, Rakesh Chopra, Michael A Danso, Henry Leonidas Gomez, N'Da Marcelin Homian, Alaa Kandil, Benda Kithaka, Bogda Koczwara, Beverly Moy, Gertrude Nakigudde, Fernando Enrique Petracci, Hope S Rugo, Nagi S El Saghir, Banu K Arun
Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified Guideline. JCO global oncology 10 (2024)
Nagi S El Saghir, Lana E Khalil, Joud El Dick, Rula W Atwani, Nadine Safi, Maya Charafeddine, Ahmad Al-Masri, Bassem N El Saghir, Maha Chaccour, Arafat Hussein Tfayli, Hazem I Assi, Jaber Abbas, Zeina Ayoub, Eman Sbaity, Hiba A Moukadem
Improved Survival of Young Patients With Breast Cancer 40 Years and Younger at Diagnosis. JCO global oncology 9 (2023)
Yen-Shen Lu, Seock-Ah Im, Marco Colleoni, Fabio Franke, Aditya Bardia, Fatima Cardoso, Nadia Harbeck, Sara Hurvitz, Louis Chow, Joohyuk Sohn, Keun Seok Lee, Saul Campos-Gomez, Rafael Villanueva Vazquez, Kyung Hae Jung, K Govind Babu, Paul Wheatley-Price, Michelino De Laurentiis, Young-Hyuck Im, Sherko Kuemmel, Nagi S El Saghir, Ruth O'Regan, Claudia Gasch, Nadia Solovieff, Craig Wang, Yongyu Wang, Arunava Chakravartty, Yan Ji, Debasish Tripathy
Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (5) (2022)
Nagi S El Saghir, Hady Ghanem, Fadi El Karak, Fadi Farhat, Marwan Ghosn, Joseph Makdessi, Khouloud Chouaib, Jamil Debs, Adel B Tabchy
Management of breast cancer patients with BRCA gene mutations in Lebanon of the Middle East: perspectives and challenges. Hospital practice (1995) (2021)
Hesham Elghazaly, Hope S Rugo, Hamdy A Azim, Sandra M Swain, Banu Arun, Matti Aapro, Edith A Perez, Benjamin O Anderson, Frederique Penault-Llorca, PierFranco Conte, Nagi S El Saghir, Cheng-Har Yip, Marwan Ghosn, Philip M P Poortmans, Mohamed A Shehata, Armando E Giuliano, Jessica W T Leung, Valentina Guarneri, Joseph Gligorov, Bahadir M Gulluoglu, Hany Abdel Aziz, Mona Frolova, Mohamed Sabry, Charles M Balch, Roberto Orecchia, Heba M El-Zawahry, Sana A Al Sukhun, Khaled Abdel Karim, Alaa Kandil, Ruslan M Paltuev, Meteb Foheidi, Mohamed El-Shinawi, Manal ElMahdy, Omalkhair Abulkhair, Wentao Yang, Adel T Aref, Joaira Bakkach, Nermean Bahie Eldin, Hagar I Elghazawy
Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast Cancer. Cancers 13 (9) (2021)
Miriam Mutebi, Benjamin O Anderson, Catherine Duggan, Clement Adebamowo, Gaurav Agarwal, Zipporah Ali, Peter Bird, Jean-Marc Bourque, Rebecca DeBoer, Luiz Henrique Gebrim, Riccardo Masetti, Shahla Masood, Manoj Menon, Gertrude Nakigudde, Anne Ng'ang'a, Nixon Niyonzima, Anne F Rositch, Karla Unger-Saldaña, Cynthia Villarreal Garza, Allison Dvaladze, Nagi S El Saghir, Julie R Gralow, Alexandru E Eniu
Breast cancer treatment: A phased approach to implementation. Cancer (2021)
Hiba A Moukadem, Ahmad Al Masry, Rula W Atwani, Firas Kreidieh, Lana E Khalil, Rita Saroufim, Sarah Daouk, Iman Abou Dalle, Nagi S El Saghir
Genetic Counseling, Screening and Risk-Reducing Surgery in Patients with Primary Breast Cancer and Germline BRCA Mutations: Unmet Needs in Low- and Middle-Income Countries. European journal of breast health 18 (1) (2021)